Table 1.
Patient characteristics
| DU 1.5 mg N = 392 |
DU 0.75 mg N = 395 |
All DU N = 787 |
|
|---|---|---|---|
| Sex | |||
| Male, n (%) | 230 (58.7) | 234 (59.2) | 464 (59.0) |
| Female, n (%) | 162 (41.3) | 161 (40.8) | 323 (41.0) |
| Age (years) | 53.8 (10.2) | 54.0 (9.9) | 53.9 (10.0) |
| Body weight (kg) | 70.7 (11.6) | 72.0 (12.1) | 71.4 (11.9) |
| BMI (kg/m2)a | 25.7 (3.2) | 26.1 (3.3) | 25.9 (3.3) |
| Duration of T2D (years) | 5.9 (5.0) | 5.6 (5.4) | 5.8 (5.2) |
| HbA1c (%) | 8.2 (1.1) | 8.2 (1.0) | 8.2 (1.1) |
| Fasting blood glucose (mmol/L)b | 9.5 (2.6) | 9.5 (2.4) | 9.5 (2.5) |
Values shown are for mean (SD) unless otherwise noted
HbA1c glycated hemoglobin, BMI body mass index, DU dulaglutide, N total number of patients in specified treatment arm, n number of patients in the specified category in specified treatment arm, SD standard deviation, T2D type 2 diabetes
aDU 1.5 mg, N = 392; DU 0.75 mg, N = 394; All DU, N = 786
bDU 1.5 mg, N = 391; DU 0.75 mg, N = 393; All DU, N = 784